Replies to post #128780 on Biotech Values

[ghmm]

Roche HCV:

On the presentation slides accessible from the below link, both danoprevir (RG7227) and RG7128 are listed as 2014 submissions (page 48)
http://www.roche.com/investors/ir_agenda/q3-2011.htm